Cargando…

Nuclear factor erythroid 2-related factors 1 and 2 are able to define the worst prognosis group among high-risk diffuse large B cell lymphomas treated with R-CHOEP

AIMS: Oxidative stress markers and antioxidant enzymes have previously been shown to have prognostic value and associate with adverse outcome in patients with diffuse large B cell lymphoma (DLBCL). Nuclear factor erythroid 2-related factor 1 (Nrf1) and factor 2 (Nrf2) are among the principal inducer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kari, Esa, Teppo, Hanna-Riikka, Haapasaari, Kirsi-Maria, Kuusisto, Milla Elvi Linnea, Lemma, Aurora, Karihtala, Peeter, Pirinen, Risto, Soini, Ylermi, Jantunen, Esa, Turpeenniemi-Hujanen, Taina, Kuittinen, Outi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580789/ https://www.ncbi.nlm.nih.gov/pubmed/30755497 http://dx.doi.org/10.1136/jclinpath-2018-205584

Ejemplares similares

Antithrombin III is probably not a suitable biomarker for diagnosis of primary central nervous system lymphoma
por: Kuusisto, Milla Elvi Linnea, et al.
Publicado: (2015)

Oxidative stress and redox state-regulating enzymes have prognostic relevance in diffuse large B-cell lymphoma
por: Peroja, Pekka, et al.
Publicado: (2012)

Impact of central nervous system (CNS) prophylaxis on the incidence of CNS relapse in patients with high-risk diffuse large B cell/follicular grade 3B lymphoma
por: Kuitunen, Hanne, et al.
Publicado: (2020)

Integrin alpha 10, CD44, PTEN, cadherin-11 and lactoferrin expressions are potential biomarkers for selecting patients in need of central nervous system prophylaxis in diffuse large B-cell lymphoma
por: Lemma, Siria A, et al.
Publicado: (2017)

Mutation of TP53, translocation analysis and immunohistochemical expression of MYC, BCL-2 and BCL-6 in patients with DLBCL treated with R-CHOP
por: Peroja, Pekka, et al.
Publicado: (2018)

Testis-Specific Thioredoxins TXNDC2, TXNDC3, and TXNDC6 Are Expressed in Both Testicular and Systemic DLBCL and Correlate with Clinical Disease Presentation
por: Chan, Mikko C., et al.
Publicado: (2021)

Keap1 expression has independent prognostic value in pancreatic adenocarcinomas
por: Isohookana, Joel, et al.
Publicado: (2015)

Redox Regulating Enzymes and Connected MicroRNA Regulators Have Prognostic Value in Classical Hodgkin Lymphomas
por: Karihtala, Peeter, et al.
Publicado: (2017)

Reactive Oxygen Species-Mediated Mechanisms of Action of Targeted Cancer Therapy
por: Teppo, Hanna-Riikka, et al.
Publicado: (2017)

Significance of bulky mass and residual tumor—Treated with or without consolidative radiotherapy—To the risk of relapse in DLBCL patients
por: Tokola, Susanna, et al.
Publicado: (2020)

Interim and end‐of‐treatment PET‐CT suffers from high false‐positive rates in DLBCL: Biopsy is needed prior to treatment decisions
por: Tokola, Susanna, et al.
Publicado: (2021)

High-level cytoplasmic claudin 3 expression is an independent predictor of poor survival in triple-negative breast cancer
por: Jääskeläinen, Anniina, et al.
Publicado: (2018)

Combination of Strong MMP-2 and Weak TIMP-2 Immunostainings Is a Significant Prognostic Factor in Endometrial Carcinoma
por: Honkavuori-Toivola, Maria, et al.
Publicado: (2013)

Oxidative stress and counteracting mechanisms in hormone receptor positive, triple-negative and basal-like breast carcinomas
por: Karihtala, Peeter, et al.
Publicado: (2011)

Snail promotes an invasive phenotype in lung carcinoma
por: Merikallio, Heta, et al.
Publicado: (2012)

Primary central nervous system lymphoma high incidence and poor survival in Finnish population-based analysis
por: Puhakka, Inka, et al.
Publicado: (2022)

NRF3 Decreases during Melanoma Carcinogenesis and Is an Independent Prognostic Marker in Melanoma
por: Immonen, Anni, et al.
Publicado: (2022)

Mortality among patients with low‐grade follicular lymphoma: A binational retrospective analysis
por: Rajamäki, Aino, et al.
Publicado: (2022)

The Role of Redox-Regulating Enzymes in Inoperable Breast Cancers Treated with Neoadjuvant Chemotherapy
por: Roininen, Nelli, et al.
Publicado: (2017)

The Transcription Factor Twist1 Has a Significant Role in Mycosis Fungoides (MF) Cell Biology: An RNA Sequencing Study of 40 MF Cases
por: Häyrinen, Marjaana J., et al.
Publicado: (2023)

Levels of Circulating TIMP-2 and MMP2-TIMP2 Complex Are Decreased in Squamous Cervical Carcinoma
por: Anne, Talvensaari-Mattila, et al.
Publicado: (2010)

The Sample Type used Affects the Levels of Gelatinases (MMP-2 and -9) and their Inhibitors (TIMP-1 and -2) in Circulating Blood of Healthy Controls and Breast Cancer Patients
por: Paula, Kuvaja, et al.
Publicado: (2007)

Blood Graft and Outcome After Autologous Stem Cell Transplantation in Patients With Primary Central Nervous System Lymphoma
por: Partanen, Anu, et al.
Publicado: (2021)

NRF1 and NRF2 mRNA and Protein Expression Decrease Early during Melanoma Carcinogenesis: An Insight into Survival and MicroRNAs
por: Hämäläinen, Mari, et al.
Publicado: (2019)

Mutational signatures and their association with survival and gene expression in urological carcinomas
por: Karihtala, Peeter, et al.
Publicado: (2023)

Real-time monitoring of human blood-brain barrier disruption
por: Kiviniemi, Vesa, et al.
Publicado: (2017)

Depth of invasion, tumor budding, and worst pattern of invasion: Prognostic indicators in early-stage oral tongue cancer
por: Almangush, Alhadi, et al.
Publicado: (2014)

CD34(+) Cell Mobilization, Autograft Cellular Composition and Outcome in Mantle Cell Lymphoma Patients
por: Turunen, Antti Samuli, et al.
Publicado: (2023)

Primary neuroendocrine breast carcinomas are associated with poor local control despite favourable biological profile: a retrospective clinical study
por: Roininen, Nelli, et al.
Publicado: (2017)

p53 in head and neck cancer: Functional consequences and environmental implications of TP53 mutations
por: Peltonen, Jenni K, et al.
Publicado: (2010)

Circulating matrix metalloproteinase MMP-9 and MMP-2/TIMP-2 complex are associated with spontaneous early pregnancy failure
por: Nissi, Ritva, et al.
Publicado: (2013)

Real-world Data: MCL2 Protocol Demonstrates Excellent Treatment Results Among Patients With Mantle Cell Lymphoma Not Fulfilling the Original Trial Inclusion Criteria
por: Harmanen, Minna, et al.
Publicado: (2023)

Comparison of the mutational profiles of neuroendocrine breast tumours, invasive ductal carcinomas and pancreatic neuroendocrine carcinomas
por: Karihtala, Peeter, et al.
Publicado: (2022)

Claudins in lung diseases
por: Soini, Ylermi
Publicado: (2011)

p53 immunohistochemistry in transitional cell carcinoma and dysplasia of the urinary bladder correlates with disease progression.
por: Soini, Y., et al.
Publicado: (1993)

Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma
por: Talvensaari-Mattila, A, et al.
Publicado: (2003)

Specific TP53 mutations predict aggressive phenotype in head and neck squamous cell carcinoma: a retrospective archival study
por: Peltonen, Jenni K, et al.
Publicado: (2011)

A minor role of asparaginase in predisposing to cerebral venous thromboses in adult acute lymphoblastic leukemia patients
por: Roininen, Saara, et al.
Publicado: (2017)

The mutational signatures of cancer: can passengers set a direction for prognosis?
por: Karihtala, Peeter
Publicado: (2023)

The Association of Metformin, Other Antidiabetic Medications and Statins on the Prognosis of Rectal Cancer in Patients with Type 2 Diabetes: A Retrospective Cohort Study
por: Erkinantti, Sami, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2dhraahddbcju4gjmode68kv03